Guo Wen-juan, Jin Zhu, Wang Ai-ying
Department of Gastroenterology, the Third Hospital of Peking University, Beijing 100191, China.
Zhonghua Zhong Liu Za Zhi. 2012 Mar;34(3):182-6. doi: 10.3760/cma.j.issn.0253-3766.2012.03.005.
To investigate the expression of apoptosis-related protein Bcl-w in adenocarcinoma of the small intestine, and the apoptotic effect of Bcl-w siRNA on small intestinal adenocarcinoma cells HuTu-80.
Forty-two tissue samples were examined in our study, including 7 cases from human small intestinal adenocarcinoma, and 35 cases from normal small intestine served as control. The expression of Bcl-w was detected by immunohistochemistry (IHC). Western blot analysis was performed to confirm whether Bcl-w siRNA could effectively down-regulate Bcl-w protein after HuTu-80 cells were transfected with Bcl-w siRNA. The cells were treated with chemotherapeutic agent 5-Fu to observe whether Bcl-w protein-silecing affects the pro-apoptotic effect of 5-Fu. Flow cytometry analysis was used for assessment of apoptotic rate of HuTu-80 cells cultured with Bcl-w siRNA alone, with 5-Fu alone, and with combination of Bcl-w siRNA and 5-Fu, using untreated HuTu-80 cells as control.
The positive rate of Bcl-w expression was significantly higher in small intestinal adenocarcinoma than that in normal tissue (85.7% vs. 25.7%, P=0.005). Compared with the control group, Bcl-w siRNA transfection effectively down-regulated the expression of Bcl-w protein (P<0.05). The apoptosis in HuTu-80 cells was not increased significantly in Bcl-w-/-cells compared with that of control group (12.4±2.2)% vs. (8.6±1.7)% (P>0.05). However, compared with the 5-Fu group, the apoptosis in HuTu-80 cells was effectively enhanced after combination treatment with Bcl-w siRNA and 5-Fu (45.7±2.1)% vs. (71.6±3.2)% (P<0.05).
Bcl-w protein plays a significant role in the carcinogenesis of human small intestinal adenocarcinoma. Down-regulation of Bcl-w protein in small intestine adenocarcinoma HuTu-80 cells leads them susceptible to 5-Fu.
探讨凋亡相关蛋白Bcl-w在小肠腺癌中的表达,以及Bcl-w siRNA对小肠腺癌细胞HuTu-80的凋亡作用。
本研究检测了42份组织样本,其中包括7例人小肠腺癌组织样本,35例正常小肠组织样本作为对照。采用免疫组织化学(IHC)检测Bcl-w的表达。在用Bcl-w siRNA转染HuTu-80细胞后,进行蛋白质免疫印迹分析以确认Bcl-w siRNA是否能有效下调Bcl-w蛋白表达。用化疗药物5-氟尿嘧啶(5-Fu)处理细胞,观察Bcl-w蛋白沉默是否影响5-Fu的促凋亡作用。以未处理的HuTu-80细胞为对照,采用流式细胞术分析单独用Bcl-w siRNA、单独用5-Fu以及Bcl-w siRNA与5-Fu联合处理后HuTu-80细胞的凋亡率。
小肠腺癌中Bcl-w表达的阳性率显著高于正常组织(85.7% 对25.7%,P = 0.005)。与对照组相比,Bcl-w siRNA转染有效下调了Bcl-w蛋白的表达(P < 0.05)。与对照组相比,Bcl-w基因敲除细胞中HuTu-80细胞的凋亡率无显著增加(12.4±2.2)% 对(8.6±1.7)%(P > 0.05)。然而,与5-Fu组相比,Bcl-w siRNA与5-Fu联合处理后,HuTu-80细胞的凋亡率有效提高(45.7±2.1)% 对(71.6±3.2)%(P < 0.05)。
Bcl-w蛋白在人小肠腺癌的发生中起重要作用。下调小肠腺癌HuTu-80细胞中的Bcl-w蛋白使其对5-Fu敏感。